The NCRI Lymphoma Group has four subgroups that develop research in areas of strategic need.

The High-Grade Lymphoma Subgroup, chaired by Dr Christopher Fox, develops research into cancer of the lymph nodes that grows and spreads quickly.

Members:

Christopher Fox, Consultant Haematologist, Nottingham University Hospitals NHS Trust (subgroup chair)

Matthew Ahearne, Trainee, University Hospitals of Leicester NHS Trust

Arzhang Ardavan, Professor of Physics

Kirit Ardeshna, University College London Hospitals NHS Foundation Trust (UCLH)

Sally Barrington, Professor of PET Imaging, King’s College London (KCL)

Kaljit Bhuller

Gladstone Amos Burke, NIHR CRN: Cancer National Specialty Lead for Children & Young People’s Cancer, University of Cambridge

Cathy Burton, Pathologist, Leeds Teaching Hospitals NHS Trust – Leeds General Infirmary

Maria Calaminici, Consultant, Barts Health NHS Trust

Robert Carr

Sridhar Chaganti, Consultant Haematologist, Queen Elizabeth Hospital Birmingham

Laura Clifton-Hadley, Trials Group Leader, University College London (UCL)

Graham Collins, Oxford University Hospitals NHS Foundation Trust

Christina Cox

Thomas Cummin, Clinical Research Fellow/ Specialist Registrar Haematology, University of Southampton

David Cunningham, Consultant Medical Oncologist, Head of the Gastrointestinal and Lymphoma Unit and Director of Clinical Research, Royal Marsden NHS Foundation Trust

Kate Cwynarski, Consultant Haematologist, University College London Hospitals NHS Foundation Trust (UCLH)

Andrew Davies, Associate Professor And Consultant In Medical Oncology, University Hospital Southampton NHS Foundation Trust – Princess Anne Hospital

Jeff Davies

Ming-Qing Du

Jurate Dudley, Clinical Trials Officer, Guy’s and St Thomas’ NHS Foundation Trust

Martin Dyer, Professor of Haemato-Oncology, University Hospitals of Leicester NHS Trust

David Edwards

Dima El-Sharkawi

Linda Evans, Sheffield Teaching Hospitals NHS Foundation Trust

Paul Fields, Consultant Haematologist, Guy’s and St Thomas’ NHS Foundation Trust

George Follows, Consultant Haematologist, Addenbrooke’s Hospital NHS Foundation Trust

Sonia Fox, University of Birmingham

Mary Gleeson

Daniel Hodson, Honorary Consultant Haematologist, University of Cambridge

Tim Illidge, Clinical Oncologist Professor of Targeted Therapy & Oncology, Head of Division of Cancer Sciences, University of Manchester

Sunil Iyengar

Rod Johnson

Nagesh Kalalonda, University of Liverpool

Shireen Kassam

Amy Kirkwood, Senior Statistician, Cancer Research UK (CRUK) London – Clinical Trials Unit @ University College London (UCL)

Andrea Kuhnl

Jonathan Lambert, University College London Hospitals NHS Foundation Trust (UCLH)

Dr David Lewis, Plymouth Hospitals NHS Trust

Sean Lim, Associate Professor and Honorary Consultant in Haematological Oncology, No affiliation

David Linch

Kim Linton, Honorary Consultant in Medical Oncology, University of Manchester

Maria Marzolini, , University College London (UCL)

Pam McKay, NHS Greater Glasgow and Clyde

Andrew McMillan, Consultant Haematologist, Nottingham University Hospitals NHS Trust

Tobias Menne, Newcastle upon Tyne Hospitals NHS Foundation Trust

George Mikhaeel, Clinical Lead – Clinical Oncology, Guy’s and St Thomas’ NHS Foundation Trust

Jessica Okosun, Queen Mary University of London

Wendy Osborne, Consultant Haematologist, Newcastle upon Tyne Hospitals NHS Foundation Trust

Wendy Osborne, Consultant Haematologist, Newcastle upon Tyne Hospitals NHS Foundation Trust

Ann Parfett

Russell Patmore, Hull Royal Infirmary

Ruth Pettengell, Consultant, St George’s, University of London

Andrew Pettitt, Professor of Haematology Molecular and Clinical Cancer Medicine, University of Liverpool

Beth Phillips, Lymphoma Clinical Trials Fellow, University College London (UCL)

John Radford, Professor of Medical Oncology, University of Manchester

Emma Searle, Clinical Lecturer and Honorary Consultant Haematologist, University of Manchester

Nimish Shah, Consultant Haematologist, University of East Anglia (UEA)

Oonagh Sheehy, Consultant Haematologist, Belfast City Hospital

Shamyla Siddique, Haematology Trials Team Leader, University of Birmingham

Dr Jeff Smith, Aintree University Hospital

Louise Stanton, Principal Medical Statistician, University of Southampton

Mary Taj, Institute of Cancer Research (ICR)

Simon Wagner

Renata Walewska

Harriet Walter, Spr Medical Oncologycancer Research Uk And Clinical Trials Fellow, University Hospitals of Leicester NHS Trust

Andrew Webb, Consultant Oncologist, Brighton and Sussex University Hospitals NHS Trust

The Hodgkin Lymphoma Subgroup, chaired by Dr Graham Collins, develops research into cancer of the lymphatic system.

Members:

Graham Collins, Oxford University Hospitals NHS Foundation Trust (subgroup chair)

Arzhang Ardavan, Professor of Physics

Sally Barrington, Professor of PET Imaging, King’s College London (KCL)

Cathy Burton, Pathologist, Leeds Teaching Hospitals NHS Trust – Leeds General Infirmary

Laura Clifton-Hadley, Trials Group Leader, University College London (UCL)

David Cutter, Consultant Clinical Oncologist and Clinical Research Fellow, Oxford University Hospitals NHS Foundation Trust

Eve Gallop-Evans, Velindre Cancer Centre

Georgina Hall

Sunil Iyengar

Ruth Jarrett, Professor of Molecular Pathology, University of Glasgow

Craig Jones

Amy Kirkwood, Senior Statistician, Cancer Research UK (CRUK) London – Clinical Trials Unit @ University College London (UCL)

Andrea Kuhnl

Rifca Le Dieu

Chiara Lobetti

Ram Malladi, Consultant Haematologist, Addenbrooke’s Hospital NHS Foundation Trust

Pam McKay, NHS Greater Glasgow and Clyde

Andrew McMillan, Consultant Haematologist, Nottingham University Hospitals NHS Trust

Patrick Medd, King’s College London (KCL)

Fiona Miall, University Hospitals of Leicester NHS Trust

Jessica Okosun, Queen Mary University of London

Wendy Osborne, Consultant Haematologist, Newcastle upon Tyne Hospitals NHS Foundation Trust

Shankara Paneesha

Karl Peggs, University College London (UCL)

Andrew Pettitt, Professor of Haematology Molecular and Clinical Cancer Medicine, University of Liverpool

Beth Phillips, Lymphoma Clinical Trials Fellow, University College London (UCL)

John Radford, Professor of Medical Oncology, University of Manchester

Nimish Shah

Ananth Shankar, Honorary Senior Lecturer & Consultant in Paediatric & Adolescent Oncology, University College London Hospitals NHS Foundation Trust (UCLH)

Louise Stanton, Principal Medical Statistician, University of Southampton

Amit Sud, Institute of Cancer Research (ICR)

Ghada Zakout

The Low-Grade Lymphoma Subgroup, chaired Dr Kim Linton, develops research into cancer of the lymph nodes that is usually very slow-growing.

Members:

Kim Linton, Honorary Consultant in Medical Oncology, University of Manchester (subgroup chair)

Kirit Ardeshna, University College London Hospitals NHS Foundation Trust (UCLH)

Nicola Bienz, Heatherwood and Wexham Park Hospital

Dr Mark Bishton, Nottingham University Hospitals NHS Trust

Toby Eyre, University of Oxford

Peter Hoskin, Professor of Clinical Oncology, Mount Vernon Cancer Centre

Sunil Iyengar

Chiara Lobetti

Pam McKay, NHS Greater Glasgow and Clyde

Dr Geetha Menon, Haematopathologist, Liverpool University Hospitals NHS Foundation Trust

Jessica Okosun, Queen Mary University of London

Andrew Pettitt, Professor of Haematology Molecular and Clinical Cancer Medicine, University of Liverpool

Malcolm Rhodes, NCRI Consumer, National Cancer Research Institute (NCRI)

Renata Walewska

The Science Lymphoma Subgroup, chaired by Professor Jude Fitzgibbon, develops research into the underlying science of cancer of the lymphatic system.

Members:

Jude Fitzgibbon, Professor of Personalised Cancer Medicine, Queen Mary University of London (subgroup chair)

Matthew Ahearne, Trainee, University Hospitals of Leicester NHS Trust

Sharon Barrans, Clinical Scientist, Leeds Teaching Hospitals NHS Trust – Leeds General Infirmary

Sally Barrington, Professor of PET Imaging, King’s College London (KCL)

Simon Bomken, Newcastle University

Cathy Burton, Pathologist, Leeds Teaching Hospitals NHS Trust – Leeds General Infirmary

Christopher Carey, Clinical Research Fellow & Honorary Consultant Haematologist, Newcastle University

Graham Collins, Oxford University Hospitals NHS Foundation Trust

Andrew Davies, Associate Professor And Consultant In Medical Oncology, University Hospital Southampton NHS Foundation Trust – Princess Anne Hospital

Ming-Qing Du

Christopher Fox, Consultant Haematologist, Nottingham University Hospitals NHS Trust

Daniel Hodson, Honorary Consultant Haematologist, University of Cambridge

Tim Illidge, Clinical Oncologist Professor of Targeted Therapy & Oncology, Head of Division of Cancer Sciences, University of Manchester

Ruth Jarrett, Professor of Molecular Pathology, University of Glasgow

Nagesh Kalalonda, University of Liverpool

Rifca Le Dieu

Sean Lim, Associate Professor and Honorary Consultant in Haematological Oncology

Kim Linton, Honorary Consultant in Medical Oncology, University of Manchester

Simon Mitchell, Lecturer in Cancer Research, Brighton and Sussex University Hospitals NHS Trust

Jessica Okosun, Queen Mary University of London

Andrew Pettitt, Professor of Haematology Molecular and Clinical Cancer Medicine, University of Liverpool

Martin Turner, Researcher, Babraham Institute